The University of Cambridge is embarking on a programme of scientific open collaboration with GlaxoSmithKline (GSK) that will involve working alongside GSK scientists and other partner organisations, to advance drug discovery and the development of new medicines.
Researchers will be based at Stevenage Bioscience Catalyst, the UKs first open innovation bioscience campus, co-located with GSKs Research and Development centre. This bioscience park provides an independent scientific community allowing scientists to foster relationships across organisations and share their expertise and knowledge.
To read the full, original article click on this link: University of Cambridge launches Open Innovation drug discovery initiative with GSK an article by Scientist Live created for Food and Laboratory Scientists
